These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20870461)

  • 1. Therapeutic potential of LIF in multiple sclerosis.
    Slaets H; Hendriks JJ; Stinissen P; Kilpatrick TJ; Hellings N
    Trends Mol Med; 2010 Nov; 16(11):493-500. PubMed ID: 20870461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
    Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair.
    Marriott MP; Emery B; Cate HS; Binder MD; Kemper D; Wu Q; Kolbe S; Gordon IR; Wang H; Egan G; Murray S; Butzkueven H; Kilpatrick TJ
    Glia; 2008 Apr; 56(6):686-98. PubMed ID: 18293407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease.
    Cao W; Yang Y; Wang Z; Liu A; Fang L; Wu F; Hong J; Shi Y; Leung S; Dong C; Zhang JZ
    Immunity; 2011 Aug; 35(2):273-84. PubMed ID: 21835648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
    Janssens K; Van den Haute C; Baekelandt V; Lucas S; van Horssen J; Somers V; Van Wijmeersch B; Stinissen P; Hendriks JJ; Slaets H; Hellings N
    Brain Behav Immun; 2015 Mar; 45():180-8. PubMed ID: 25514345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis.
    Slaets H; Hendriks JJ; Van den Haute C; Coun F; Baekelandt V; Stinissen P; Hellings N
    Mol Ther; 2010 Apr; 18(4):684-91. PubMed ID: 20068552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF.
    Laterza C; Merlini A; De Feo D; Ruffini F; Menon R; Onorati M; Fredrickx E; Muzio L; Lombardo A; Comi G; Quattrini A; Taveggia C; Farina C; Cattaneo E; Martino G
    Nat Commun; 2013; 4():2597. PubMed ID: 24169527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of human adipose-derived stem cells overexpressing LIF/IFN-β promotes recovery in experimental autoimmune encephalomyelitis (EAE).
    Yousefi M; Nabipour A; Ganjalikhani Hakemi M; Ashja-Arvan M; Amirpour N; Salehi H
    Sci Rep; 2022 Oct; 12(1):17835. PubMed ID: 36284106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival.
    Butzkueven H; Zhang JG; Soilu-Hanninen M; Hochrein H; Chionh F; Shipham KA; Emery B; Turnley AM; Petratos S; Ernst M; Bartlett PF; Kilpatrick TJ
    Nat Med; 2002 Jun; 8(6):613-9. PubMed ID: 12042813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L; Annunziata P; Sessa E; Bramanti P
    J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
    Mirowska-Guzel D
    Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders.
    Slavin S; Kurkalli BG; Karussis D
    Clin Neurol Neurosurg; 2008 Nov; 110(9):943-6. PubMed ID: 18325660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of leukemia inhibitory factor on embryonic stem cell differentiation: implications for supporting neuronal differentiation.
    He Z; Li JJ; Zhen CH; Feng LY; Ding XY
    Acta Pharmacol Sin; 2006 Jan; 27(1):80-90. PubMed ID: 16364214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system.
    Furlan R; Pluchino S; Martino G
    Curr Opin Neurol; 2003 Jun; 16(3):385-92. PubMed ID: 12858077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Humle Jorgensen S; Sorensen PS
    J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience.
    Karussis D; Kassis I
    Clin Neurol Neurosurg; 2008 Nov; 110(9):889-96. PubMed ID: 18375051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicine: Collateral damage repaired.
    Steinman L
    Nature; 2003 Apr; 422(6933):671-2. PubMed ID: 12700743
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis.
    Tham E; Gielen AW; Khademi M; Martin C; Piehl F
    Scand J Immunol; 2006 Dec; 64(6):609-22. PubMed ID: 17083617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Enhancers of the Secretion of Leukemia Inhibitory Factor for the Treatment of Multiple Sclerosis.
    Vela L; Caballero I; Fang L; Liu Q; Ramón F; Díez E; de Los Frailes M
    J Biomol Screen; 2016 Jun; 21(5):437-45. PubMed ID: 26984928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.